Prophylactic oral antiemetics for preventing postoperative nausea and vomiting: Granisetron versus domperidone

Anesthesia and Analgesia

Volumn 87, Issue 6, 1998, Pages 1404-1407

  Fujii, Yoshitaka ^a   Saitoh, Yuhji ^b   Tanaka, Hiroyoshi ^b   Toyooka, Hidenori ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; GRANISETRON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GYNECOLOGIC SURGERY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; VOMITING;

EID: 0031737686     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199812000-00037     Document Type: Article

References (11)

1. Bermudez J, Boyle EA, Minter WD, Sanger GJ. The antiemetic potential of the 5-hydroxytryptamine, receptor antagonist BRL 43694. Br J Cancer 1988;58:644-50.
2. Andrews PLR, Bhandari P, Davey PT, et al. Are all 5-HT3 receptor antagonists the same? Eur J Cancer 1992;28:S2-6.
3. Fujii Y, Tnnaka H, Toyooka H. Reduction of postoperative nausea and vomiting with granisetron. Can J Anaesth 1994;41:291-4.
4. Fujii Y, Tanaka H, Toyooka H. Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting. Can J Anaesth 1994;41:794-7.
5. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;77:-162-84.
6. Maissno R, Adamo V, Settineri K, et al. Efficacy of two oral dose regimens of granisetron. Anticancer Res 1995;15:2287-90.
7. Fujii Y, Tanaka H, Toyooka H. Preoperative oral granisetron prevents postoperative nausea and vomiting. Acta Anaesthesiol Scand 1998;42:653-7.
8. Brogden RN, Carmine AA, Heel RC, et al. Domperidone: a review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982;24:360-400.
9. 3 receptor antagonist: correlation of anti-emetic response. Cancer Chemother Pharmacoi 1989;24:45-9.
10. Kudoh S, Okada H, Miyazakl R, et al. A phase I study of granisetron hydrochloride: pharmacokinetics of granisetron following single oral administration in healthy Japanese subjects. Jpn Pharmacoi Ther 1993;21:169-76.
11. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ 1995;311:844-6.